Carlton Hofferkamp & Jenks Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.61M | Sell |
4,387
-23
| -0.5% | -$7.87K | 0.52% | 42 |
|
|
2026
Q1 | $1.5M | Hold |
4,410
| – | – | 0.5% | 45 |
|
|
2025
Q4 | $1.44M | Sell |
4,410
-50
| -1% | -$15.9K | 0.48% | 43 |
|
|
2025
Q3 | $1.3M | Sell |
4,460
-221
| -5% | -$64.1K | 0.44% | 49 |
|
|
2025
Q2 | $1.41M | Sell |
4,681
-40
| -0.8% | -$11.3K | 0.51% | 42 |
|
|
2025
Q1 | $1.33M | Hold |
4,721
| – | – | 0.55% | 43 |
|
|
2024
Q4 | $1.45M | Sell |
4,721
-68
| -1% | -$20.2K | 0.54% | 42 |
|
|
2024
Q3 | $1.52M | Sell |
4,789
-71
| -1% | -$23.2K | 0.58% | 41 |
|
|
2024
Q2 | $1.62M | Sell |
4,860
-30
| -0.6% | -$8.81K | 0.63% | 38 |
|
|
2024
Q1 | $1.32M | Buy |
4,890
+45
| +0.9% | +$13.2K | 0.55% | 44 |
|
|
2023
Q4 | $1.48M | Sell |
4,845
-109
| -2% | -$29.7K | 0.62% | 41 |
|
|
2023
Q3 | $1.35M | Sell |
4,954
-420
| -8% | -$105K | 0.63% | 40 |
|
|
2023
Q2 | $1.31M | Sell |
5,374
-52
| -1% | -$12.1K | 0.58% | 43 |
|
|
2023
Q1 | $1.27M | Sell |
5,426
-64
| -1% | -$15.7K | 0.58% | 46 |
|
|
2022
Q4 | $1.39M | Sell |
5,490
-98
| -2% | -$26.3K | 0.61% | 42 |
|
|
2022
Q3 | $1.41M | Sell |
5,588
-89
| -2% | -$21.6K | 0.66% | 42 |
|
|
2022
Q2 | $1.41M | Buy |
5,677
+5
| +0.1% | +$1.23K | 0.65% | 43 |
|
|
2022
Q1 | $1.43M | Buy |
5,672
+50
| +0.9% | +$11.5K | 0.59% | 47 |
|
|
2021
Q4 | $1.26M | Buy |
5,622
+225
| +4% | +$47.5K | 0.53% | 53 |
|
|
2021
Q3 | $1.14M | Buy |
5,397
+746
| +16% | +$172K | 0.46% | 60 |
|
|
2021
Q2 | $1.15M | Buy |
4,651
+211
| +5% | +$51.9K | 0.5% | 55 |
|
|
2021
Q1 | $1.13M | Buy |
4,440
+30
| +0.7% | +$7.16K | 0.5% | 52 |
|
|
2020
Q4 | $1.09M | Sell |
4,410
-5
| -0.1% | -$1.15K | 0.54% | 53 |
|
|
2020
Q3 | $1.06M | Buy |
4,415
+95
| +2% | +$23.5K | 0.56% | 50 |
|
|
2020
Q2 | $1.07M | Sell |
4,320
-305
| -7% | -$69.6K | 0.61% | 46 |
|
|
2020
Q1 | $1.09M | Buy |
4,625
+50
| +1% | +$10.9K | 0.67% | 42 |
|
|
2019
Q4 | $1.02M | Sell |
4,575
-119
| -3% | -$26.2K | 0.57% | 47 |
|
|
2019
Q3 | $933K | Buy |
4,694
+50
| +1% | +$9.6K | 0.57% | 47 |
|
|
2019
Q2 | $822K | Buy |
4,644
+332
| +8% | +$59.4K | 0.5% | 51 |
|
|
2019
Q1 | $819K | Buy |
4,312
+101
| +2% | +$19.3K | 0.51% | 52 |
|
|
2018
Q4 | $819K | Hold |
4,211
| – | – | 0.59% | 47 |
|
|
2018
Q3 | $873K | Hold |
4,211
| – | – | 0.54% | 50 |
|
|
2018
Q2 | $777K | Hold |
4,211
| – | – | 0.5% | 51 |
|
|
2018
Q1 | $717K | Hold |
4,211
| – | – | 0.48% | 52 |
|
|
2017
Q4 | $732K | Sell |
4,211
-40
| -0.9% | -$7.08K | 0.46% | 56 |
|
|
2017
Q3 | $792K | Sell |
4,251
-80
| -2% | -$14.2K | 0.51% | 56 |
|
|
2017
Q2 | $745K | Sell |
4,331
-100
| -2% | -$16.3K | 0.51% | 53 |
|
|
2017
Q1 | $726K | Buy |
+4,431
| New | +$736K | 0.51% | 51 |
|
Other funds holding AMGN
FFM
SP
Carlton Hofferkamp & Jenks Wealth Management's AMGN Position: Q2 2026 in Review
Carlton Hofferkamp & Jenks Wealth Management reduced its Amgen (AMGN) stake by 0.52% in Q2 2026, selling an estimated $7.87K and leaving 4,387 shares worth $1.61M. The position accounts for 0.52% of the portfolio, ranked #42.
Carlton Hofferkamp & Jenks Wealth Management first reported a position in AMGN in Q1 2017 and has held it in 38 quarters since. The position peaked at $1.62M in Q2 2024. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Carlton Hofferkamp & Jenks Wealth Management held 4,387 shares of Amgen worth $1.61M as of Q2 2026.
- Carlton Hofferkamp & Jenks Wealth Management sold 23 Amgen shares in Q2 2026, an estimated $7.87K.
- Amgen made up 0.52% of Carlton Hofferkamp & Jenks Wealth Management's portfolio in Q2 2026, its #42 holding.
- Carlton Hofferkamp & Jenks Wealth Management first reported a position in Amgen in Q1 2017 and has held it in 38 quarters since.
- Carlton Hofferkamp & Jenks Wealth Management's Amgen position peaked at $1.62M in Q2 2024.
- 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Carlton Hofferkamp & Jenks Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.